- Location
age related macular degeneration
"-
Cancer Diagnostics to Drive Coherence Tomography Market Growth
Nov 5, 2015The emergence of applications in cancer diagnostics, cardiology and gastroenterology will help drive the market for clinical optical imaging to $2 billion by the end of the decade. That’s according to a new market report from the ...
Tags: Cancer Diagnostics, optical technologies, ultrasound technologies
-
Moderate Aerobic Exercise Helps to Preserve The Structure and Function of Nerve Cells
Feb 25, 2014Moderate aerobic exercise helps to preserve the structure and function of nerve cells in the retina after damage, according to an animal study appearing February 12 in The Journal of Neuroscience. The findings suggest exercise may be able ...
Tags: Aerobic Exercise, Nerve Cells, BNDF, blind disease
-
The List of Health Woes Linked to Smoking Is Like a Scroll That Keeps Unfurling
Jan 18, 2014The list of health woes linked to smoking is like a scroll that keeps unfurling. At a White House press conference Friday morning, half a century after the release of the historic 1964 Surgeon General's report, dozens of the nation's ...
-
Unilife Has Announced The Signing of an Agreement
Dec 18, 2013Unilife, a medical device and technology company, has announced the signing of an agreement with a global pharmaceutical company seeking to use the Unilife Ocu-ject ocular drug delivery system to deliver a target injectable therapy into the ...
Tags: Unilife, medical device
-
Bayer HealthCare Has Submitted VEGF Trap-Eye for Regulatory Approval in Japan
Dec 5, 2013Bayer HealthCare has submitted VEGF Trap-Eye (aflibercept solution for injection) for regulatory approval in Japan to treat patients with myopic choroidal neovascularization (myopic CNV), one of the most common causes of eye disease. In ...
-
Bayer and Regeneron Pharmaceuticals Are Collaborating on The Global Development of Eylea
Nov 26, 2013Japan's Ministry of Health, Labour and Welfare (MHLW) has approved Bayer HealthCare's Eylea (aflibercept, solution for intravitreal injection) for the treatment of macular edema secondary to central retinal vein occlusion (CRVO). In ...
-
Oraya Therapeutics Announced Initial Three-Year Safety Follow-up Data From Its Study
Nov 19, 2013Oraya Therapeutics announced that initial three-year safety follow-up data from its INTREPID study of Oraya Therapy stereotactic radiotherapy for the treatment of wet age-related macular degeneration (AMD) were presented for the first time ...
Tags: Oraya Therapeutics, Medicine
-
Fuse Science Announced Further Advancements of Technology Partnership with Macular Health
Nov 19, 2013Fuse Science has announced further advancements of its technology partnership with Macular Health. Fuse Science is a consumer products and delivery technology company that is developing new, patent-pending technologies poised to redefine ...
Tags: Fuse Science Technology, Medicine
-
Bayer Has Received Approval From Health Canada for Eylea for Treatment of Patients
Nov 15, 2013Bayer has received approval from Health Canada for Eylea (aflibercept, solution for intravitreal injection) for treatment of patients with neovascular (wet) age-related macular degeneration (wet AMD). AMD, a progressive eye disease that ...
Tags: Wet AMD Patients, Bayer
-
Allegro Ophthalmics Has Received Approval From FDA for IND Application
Oct 11, 2013Allegro Ophthalmics has received approval from the US Food and Drug Administration (FDA) for its Investigational New Drug (IND) application to commence two Phase II clinical studies of integrin peptide therapy ALG-1001. The new trials, ...
Tags: Eye Disease Patients
-
European Commission Has Approved Regeneron Pharmaceuticals's Eylea Injection
Sep 2, 2013The European Commission has approved Regeneron Pharmaceuticals's Eylea (aflibercept) injection for the treatment of visual impairment caused by macular edema secondary to central retinal vein occlusion (CRVO). Eylea is a recombinant ...
Tags: fusion protein, Eylea
-
Biomedical Engineers Have Partnered with Clinicians to Create Therapeutic Eye Injections
Aug 26, 2013Biomedical engineers from The Johns Hopkins University have partnered with clinicians to create new therapeutic eye injections for a type of central vision loss caused by blood vessel growth at the back of the eye. The new drug, with a ...
-
Lpath Has Won a US patent
May 31, 2013Lpath has won a US patent covering methods of using monoclonal antibodies for the treatment and prevention of ocular conditions, including wet age-related macular degeneration (AMD). The patent includes the use of monoclonal antibodies, ...
-
A Number of Steps Can Help Prevent Disease of Your Summer in Summer
May 15, 2013Summer sun increases the risk of age-related macular degeneration, the leading cause of blindness in adults. A number of steps can help prevent that disease, as well as your risk of developing cataracts, diabetic retinopathy, and glaucoma. ...
Tags: Eyes, Summer, Health&Medicine
-
USPTO Has Granted a NOA to Retrosense Therapeutics' Patent Application
Mar 8, 2013The US Patent and Trademark Office (USPTO) has granted a notice of allowance (NOA) to RetroSense Therapeutics' patent application No. 12/299,574 covering methods of restoring visual responses with various optogenetic compounds. The ...
Tags: RetroSense, vision restoration approaches, RetroSense Therapeutics
